A medication for multi-drug-resistant tuberculosis, bedaquiline, will soon become available in South Africa after being preliminarily cleared by the U.S. drug authority. The prospect is welcomed by health groups who say there is a growing need for treatment in the nation with one of the world's highest HIV rates, and where TB is often the major cause of death. The drug has not cleared a full set of medical trials, but experts say the sick and dying can not wait. Dr. Dalene von Delft ...
No comments:
Post a Comment